Home > PE Ratio > ANTHEM BIOSCIENCES

ANTHEM BIOSCIENCES
PE (Price/Earnings) Ratio

The Current P/E Ratio of ANTHEM BIOSCIENCES is 82.97.

Share Price ₹848.1Oct 14,2026
Market Cap ₹47,787.6 Cr
Earnings-TTM₹575.9 CrTTM-Consolidated Results
Price/Earnings82.97xCalculated as Market Cap/Earnings
Explore Stock Analytics
COMMUNITY POLL
for ANTHEM BIOSCIENCES
Please provide your vote to see the results
ANTHEM BIOSCIENCES is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals

Definition & Calculation of PE (Price/Earnings) ratio of ANTHEM BIOSCIENCES

Price-to-Earnings ratio, P/E Multiple, or P/E Ratio is an important valuation multiple that is defined as:

P/E = Market Capitalization / Net Income

or, using per-share numbers:

P/E = Stock Price / Earnings Per Share (EPS)

Applying the above formula, P/E ratio of ANTHEM BIOSCIENCES is calculated as :

Current Market Cap [ ₹47,787.6 Cr] as on Oct 14,2026

(/) Earnings [ ₹575.9 Cr] based on TTM-Consolidated Results

(=) P/E Ratio [ 82.97x ]

P/E Ratio indicates the multiple of earnings investors are willing to pay to own one share of the company.

Thus, for ANTHEM BIOSCIENCES , the investors are currently willing to pay 82.97 times earnings to own 1 share of the company.

PE Multiples are the most widely used valuation multiple in practice.

Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.

In such cases, you may consider using Price to Book ratio or Price to Sales ratio of ANTHEM BIOSCIENCES !

P/E ratios, also, would not adjust for differences in the capital structure between companies.

The chart below summarizes the trend in P/E Ratio of ANTHEM BIOSCIENCES over the last five years.

Historical PE (Price/Earnings) ratio chart of ANTHEM BIOSCIENCES


PE Ratio Performance Analysis for ANTHEM BIOSCIENCES

- ANTHEM BIOSCIENCES 's latest p/e ratio is 82.97x.

- ANTHEM BIOSCIENCES 's p/e ratio for fiscal years ending Mar2026 to Mar2022 averaged 12.46x.

- ANTHEM BIOSCIENCES 's operated at median p/e ratio of 0x from fiscal years ending March 2018 to 2022.

- Looking back at the last 5 fiscal years, ANTHEM BIOSCIENCES 's p/e ratio peaked in Mar2026 at 62.29x.

- ANTHEM BIOSCIENCES 's p/e ratio hit its five-year low in Mar2025 of 0x.


How does ANTHEM BIOSCIENCES 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?

Peer Comparison (Pharmaceuticals & Drugs Industry)Earnings-TTM (Cr)PE RatioMarket Cap
ANTHEM BIOSCIENCES 575.9582.9747,787.6
SUN PHARMACEUTICAL INDUSTRIES LTD12,172.7034.47419,620.0
DIVIS LABORATORIES LTD2,925.0081.95239,714.0
TORRENT PHARMACEUTICALS LTD2,156.0081.05174,741.0
CIPLA LTD3,364.8431.52106,061.0
DR REDDYS LABORATORIES LTD3,169.3031.98101,339.0
MANKIND PHARMA LTD2,055.1146.8396,243.6
LUPIN LTD5,551.0116.1089,391.0
ZYDUS LIFESCIENCES LTD4,492.2024.96112,119.0
AUROBINDO PHARMA LTD3,712.7425.7595,590.4
LAURUS LABS LTD1,090.76100.85110,008.0

Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs ANTHEM BIOSCIENCES 's P/E Ratio

Top 10 Industry PeersPE Ratio
Min industry PE 16.10x
Max industry PE 100.85x
Median industry PE 34.47x
Average industry PE 50.77x



You may also like the below Video Courses